Actavis Investing $48M In Puerto Rico Plants
SAN JUAN, Puerto Rico (AP) -- Drug maker Actavis Plc is investing $48 million to reactivate and expand two manufacturing plants in the U.S. territory of Puerto Rico.
Gov. Alejandro Garcia Padilla says Actavis expects to produce about 2.5 billion tablets at a pharmaceutical plant in the north coastal town of Manati that previously served as a warehouse. Actavis also will expand a manufacturing plant based in the northeast coastal town of Fajardo.
Both plants were previously owned by Warner Chilcott, which Actavis bought in 2013 for $8.5 billion.
Garcia said Wednesday that some 300 jobs will be created in the next three years.
Actavis is based in Ireland and has grown in recent years as a result of several multibillion-dollar deals.